NYSE:MNK
Delisted
Mallinckrodt plc Stock News
$0.116
+0 (+0%)
At Close: Jul 20, 2022
Mallinckrodt reports FDA acceptance of NDA for terlipressin MNK
11:17am, Wednesday, 22'nd Apr 2020
Mallinckrodt reports FDA acceptance of NDA for terlipressin MNK
Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for
New York charges Mallinckrodt with insurance fraud over opioid claims
06:54pm, Tuesday, 21'st Apr 2020
NEW YORK — New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically u…
UPDATE 3-New York charges Mallinckrodt with insurance fraud over opioid claims
06:52pm, Tuesday, 21'st Apr 2020
New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescript
New York charges Mallinckrodt with insurance fraud over opioid claims
05:56pm, Tuesday, 21'st Apr 2020
New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescript
New York charges Mallinckrodt with insurance fraud over opioid claims
05:53pm, Tuesday, 21'st Apr 2020
NEW YORK — New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically u…
New York charges Mallinckrodt with insurance fraud related to opioids
04:37pm, Tuesday, 21'st Apr 2020
New York state charged Mallinckrodt Plc on Tuesday with insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescriptions.
UPDATE 1-New York charges Mallinckrodt with insurance fraud related to opioids
04:35pm, Tuesday, 21'st Apr 2020
(Adds allegations, stock price)
New York charges Mallinckrodt with insurance fraud over opioid claims
04:19pm, Tuesday, 21'st Apr 2020
New York state brought civil charges on Tuesday accusing Mallinckrodt Plc of insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescript
New York charges Mallinckrodt with insurance fraud related to opioids
04:07pm, Tuesday, 21'st Apr 2020
New York has charged Mallinckrodt Plc with insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescriptions.
New York charges Mallinckrodt with insurance fraud related to opioids
03:57pm, Tuesday, 21'st Apr 2020
NEW YORK, April 21 (Reuters) - New York has charged Mallinckrodt Plc with insurance fraud for misrepresenting the safety and efficacy of its opioid drugs, leading to medically unnecessary prescription
Stocks - Dow Down as Bears Sink Teeth Into Tech Amid Oil Plunge
01:18pm, Tuesday, 21'st Apr 2020
By Yasin Ebrahim
IRIDEX Announces the Appointment of Doris Engibous to its Board of Directors
12:00pm, Tuesday, 21'st Apr 2020
IRIDEX Corporation (IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the appointment of Doris Engibous to its
Should You Buy This Biotech That Makes A Lower Risk Painkiller?
10:20am, Tuesday, 21'st Apr 2020
A company making abuse-deterrent opioids and that's barely listed in any nation-wide opioid litigation is becoming a rising star despite the prescription overdose crisis.
